Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
lenvatinib
×
90 days
×
Clear all
Filters
3
NCT04977453
2026-03-17
Keynote B59
GI Innovation, Inc.
Phase 1/2
Recruiting
317 enrolled
NCT03898180
2026-02-05
LEAP-011
Merck Sharp & Dohme LLC
Phase 3
Completed
505 enrolled
19 charts